ArticleFrontiers in immunology2026

Standardized pressure provocation as an objective clinical marker of omalizumab response in delayed pressure urticaria: an open-label, real-life, prospective cohort.

George N Konstantinou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.